SEC investigations in the Pharmaceutical industry in China

12 March 2017

Leaf has represented a pharmaceutical company in an investigation made by the US Department of Justice and the Securities and Exchange Commission on distribution practices in China. Negotiation with Chinese authorities regarding the same facts.